Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Computerized Thermal Imaging CIO (formerly COII) -- Ignore unavailable to you. Want to Upgrade?

To: Smilodon who wrote (4054)	6/15/2000 5:43:00 PM
From: Srexley	Respond to of 6039

What do you mean by your last post?

To: Smilodon who wrote (4054)	6/16/2000 1:22:00 AM
From: chirodoc	Read Replies (2) \| Respond to of 6039

....storm clouds? it is 100 degrees F here and coii is getting ready to fire on all cylinders. i have no idea what you are talking about. curtis

To: Smilodon who wrote (4054)	6/17/2000 12:35:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 6039

6/17------------NEW INVESTORS POST------------------ THERE ARE INDICATIONS THAT SHORT SELLERS ARE COMING BACK TO COII TO TRY ONE MORE TIME. IF YOU NEED MORE SHARES AND THEY ARE SUCCESSFUL, I WOULD SUGGEST ADDING TO YOUR POSITION. WE ARE SO CLOSE TO GOOD NEWS THAT ANY SIGNIFICANT DROP IN PRICE WOULD RAISE THE REWARD RELATIVE TO RISK RATIO. The Annual Meeting of Stockholders (the "Annual Meeting") of Computerized Thermal Imaging, Inc. will be held in the Golden Gate "C" Room of the Marriott Hotel Downtown, 55 Fourth Street, San Francisco, CA 94103 on June 27, 2000 at 2 P.M. PST. MY GUESS ABOUT THE PIPELINE: module 2 was sent back to coii for "minor" revisions, should be going back in soon. modules 3 is in! 4 going in very soon, less than 1 month? 5 should not be far behind it--my guess is mid to late summer. foreign sales slowly coming together. nasdaq approval soon!!!! we should be approved by october-november these are just my guesses--i could be right or wrong, of course. --------------------------------------------------------- COII (CTI) is the leader in the emerging field of thermal medical imaging. They will be first to market with a computerized thermal imaging system to be used inititally as an adjunct to mammography. They have at least a one year head start on all competitors. Orders from foreign countries are already being taken(we assume)and they have plenty of funding for a fast and furious national roll-out. CTI will help stop the breast cancer epidemic. Then, they will become major players in the diagnosis of back/neck pain(work injuries), followed by many other potential areas such as dermatology, cardioloigy, etc. Their breast cancer detection system should be approved by summer/fall 2000. Use these links to help you in your study of COII. 1. Go to the Silicon Investor "research" thread and read the last 5-15 posts, at least. Subject 21613 2. Go to the company website and study it--especially the thermal images of cancer vs. normal tissue..see news release from Feb. for images: cti-net.com 3. Go to the yahoo COII "profile" biz.yahoo.com 4. Institutional buying interest has started. insidertrader.com 5. CTI may eventually replace mammography as the screening of choice for breast cancer--then it could be back/neck pain, melanoma, etc. CTI's EARNING POTENTIAL Let's assume that 1-2 years after approval: 300 imaging centers X 200,000-400,000 net/system = 60M net note: this is conservative. it is possible they could make FAR more per system. think about it: they can process 4-6 ladies per hour. each breast will NET around $30, with most women having both done for total of $60 per exam. $50 x 4/hour x 8 hr. day x 6 days/week x 50 weeks/yr. = NET of 480,000 per year. Then assume they sell sell 200 systems x 250,000 net = 50M NET ONE YEAR AFTER APPROVAL = $110M ASSUME 110M SHARES OUTSTANDING GIVES US $1/SHARE So if we assume that they have a p/e of 50 during the first couple years (this would drop to 25 after 1-2 years) it would give a stock price of: $50 with a 50 p/e or $25 with a 25 p/e My one year price projection after approval is $25-$50 My 2-3 year projection is $50-$100 My 5+ year prjection is $100-$200 These are all back of the envelope estimates and have no guidance from the company. I will update these estimates as time progresses. If anyone has any suggestions, please let me know. Please realize that all of these computations are very conservative. CTI will have a great run for at least 2-3 years. The long term investor wins with CTI. note: the above are only my estimates and could be right or wrong. curtis

To: Smilodon who wrote (4054)	6/19/2000 4:02:00 PM
From: Srexley	Read Replies (1) \| Respond to of 6039

Looks like a storm is brewing. Good call! biz.yahoo.com Monday June 19, 11:38 am Eastern Time Company Press Release CTI Announces First Sale of its New Breast Cancer Imaging System Unique Non-Invasive Advancement Aids Physicians in Diagnosis of Breast Cancer LAYTON, Utah--(BUSINESS WIRE)--June 19, 2000--Computerized Thermal Imaging, Inc. (CTI) (OTC symbol: COII - news) announced today the sale of 10 CTI breast cancer imaging systems to a Latin American consortium based in Mexico City for $5 million. This consortium, Computerized Thermal Imaging International, and CTI had previously announced an agreement to deploy 100 CTI breast cancer imaging units in Latin America. This initial purchase order was accompanied by a down payment of $1.75 million, with the balance due upon delivery of the systems. ``This is a very significant event in our corporate history,'' stated David Packer, President and COO. ``It represents the first sale of our revolutionary breast cancer imaging system and our first significant revenues. This achievement is the result of our unwavering commitment to bring this product to market successfully. Our recent acquisition of Bales Scientific will greatly enhance both production and support. We will now begin production as well as total implementation of the domestic and international product support infrastructure.'' CTI is seeking FDA approval for use of its Computerized Thermal Imaging System in the United States as an adjunctive diagnostic test to mammography and clinical examination for the detection of breast cancer. The test is simple, painless, and involves no radiation, breast compression, electrodes, electrical current, or skin contact. CTI also recently announced evaluation of their technology for new occupational medicine applications. Computerized Thermal Imaging, Inc. is in business to improve the quality of life through superior diagnostics. Information about CTI can be found on the Internet at www.cti-net.com or by calling CTI Public Affairs at (801) 926-1113. Except for historical information contained herein, the matters discussed in this news release are forward-looking statements that involve risks and uncertainties. The forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. In addition to the factors set forth above, other important factors that could cause actual results to differ materially include, but are not limited to technical risks associated with new technology development, government regulatory approvals or continued working capital. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained from time to time in the Company's SEC filings. Copies of these filings may be obtained by contacting the Company or the SEC.